Skip to main content
. 2006 Dec;1(4):375–383. doi: 10.2147/nano.2006.1.4.375

Figure 3A.

Figure 3A

Clinical plasma pharmacokinetics. Plasma samples were collected from patients receiving PPX as a 10- to 30-minute infusion once every 3 weeks. Conjugated and unconjugated paclitaxel were measured by validated HPLC/MS methods. The plasma concentration of conjugated paclitaxel declines biphasically and is characterized by a prolonged distribution phase and an elimination phase with a long terminal half-life.